Inbiobank is a non profit-making bank of stem and primary cells the function of which is to produce and characterise such cells for their use in applied research, both basic and clinical.
Inbiobank’s installations have technologically pioneering, state-of-the-art equipment. Its cell production plant has ISO 9001- 2000 quality certification and it works in and operates with GMP (Good Manufacturing Practices) conditions, thus guaranteeing the clinical quality of the cells produced. Moreover, these installations have been authorised as pharmaceutical laboratories (Nº 4206 E) by the Spanish Medication Agency to carry out clinical trials (PEI 05-057) using somatic cell therapy, only the second throughout Spain with such authorisation.
About adult stem cells
Adult stem cells are responsible for cellular and tissue regeneration and are located in various tissues of the body. Generally these are extracted from easily-accessible tissues with high capacity for renovation, such as bone marrow, skin, intestine and fatty tissue.
Thanks to their potential therapeutic and regenerative activity, adult stem cells provide multiple possibilities for the treatment of many pathologies. Moreover, given their adult origin, they are free of the legal and ethical problems associated with stem cells originating from other sources.
Basic research at Inbiomed
Currently, Inbiomed is working on three main lines of basic research, all based on the study of adult stem cells of human origin and that come from a number of different tissues:
· bone marrow, umbilical cord and adipose tissue stem cells
· skin stem cells
· neuronal stem cells
Within these lines of research, Inbiomed is studying the mechanisms, both genetic and biochemical, that intervene in the multiplication and differentiation of these cells in the various body tissues as well as in their biological function. The quest is also to find ways of reconstituting in vitro the environment in which these adult stem cells multiply and differentiate.
Clinical research at Inbiomed
The Inbiomed Foundation is participating, together with the Spanish Consortium for Epidermolisis Bullosa in clinical trials (PEI 05- 057) the aim of which is to test the efficacy and safety of a new treatment for Epidermolisis Bullosa, and based on the use of engineered chimeric bilaminar skin (produced artificially in the pharmaceutical laboratory), and compare it with a current commercial treatment.
Irati Kortabitarte | alfa
22.02.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau
Separate brain systems cooperate during learning, study finds
22.02.2018 | Brown University
Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...
For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.
In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...
Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale
Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...
For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.
But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...
Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.
The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...
15.02.2018 | Event News
13.02.2018 | Event News
12.02.2018 | Event News
22.02.2018 | Life Sciences
22.02.2018 | Physics and Astronomy
22.02.2018 | Earth Sciences